CVS Health Co. (NYSE:CVS) Shares Sold by Affinity Investment Advisors LLC

Affinity Investment Advisors LLC lowered its position in shares of CVS Health Co. (NYSE:CVS) by 32.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,670 shares of the pharmacy operator’s stock after selling 8,158 shares during the quarter. Affinity Investment Advisors LLC’s holdings in CVS Health were worth $1,048,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Gladstone Institutional Advisory LLC boosted its stake in CVS Health by 24.2% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 14,556 shares of the pharmacy operator’s stock worth $915,000 after purchasing an additional 2,832 shares during the last quarter. Silver Coast Investments LLC boosted its position in CVS Health by 16.0% during the third quarter. Silver Coast Investments LLC now owns 8,950 shares of the pharmacy operator’s stock worth $563,000 after acquiring an additional 1,236 shares during the last quarter. Focus Financial Network Inc. grew its stake in CVS Health by 2.9% during the 3rd quarter. Focus Financial Network Inc. now owns 18,061 shares of the pharmacy operator’s stock valued at $1,136,000 after acquiring an additional 512 shares in the last quarter. Reston Wealth Management LLC purchased a new position in CVS Health in the 3rd quarter worth approximately $32,000. Finally, United Asset Strategies Inc. boosted its holdings in shares of CVS Health by 2.4% during the 3rd quarter. United Asset Strategies Inc. now owns 9,217 shares of the pharmacy operator’s stock worth $580,000 after purchasing an additional 212 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Barclays cut their price target on CVS Health from $82.00 to $75.00 and set an “overweight” rating for the company in a report on Wednesday, October 23rd. Royal Bank of Canada reiterated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. Truist Financial upped their price objective on shares of CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a report on Friday, October 11th. Wells Fargo & Company lifted their target price on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Finally, Evercore ISI increased their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Nine investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $74.58.

CVS Health Stock Performance

NYSE:CVS opened at $55.81 on Friday. The company has a market cap of $70.21 billion, a price-to-earnings ratio of 9.93, a price-to-earnings-growth ratio of 0.83 and a beta of 0.54. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The company has a fifty day simple moving average of $59.66 and a two-hundred day simple moving average of $59.62.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.21 EPS. As a group, equities analysts anticipate that CVS Health Co. will post 6.41 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.77%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is 47.33%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.